A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models

Abstract

In preclinical models, both risperidone and paliperidone exhibited notable metabolic side-effects that were dose-dependent. Differences between the two were modest, and most notable as effects on fasting glucose.